The N36 AVIO is an advanced biocontainment system for the safe air transport of infectious patients during aeromedical evacuation missions. Developed from the N36 isolation platform, it introduces certified structural restraint systems, dedicated aeronautical integration solutions, and specific operational features for use aboard helicopters.
The system is designed to ensure the safe transport of infectious patients, the protection of flight crew and medical personnel, compliance with aviation safety requirements, rapid deployment in emergency situations, and compatibility with major military and civil evacuation procedures.
The N36 AVIO operates under negative pressure conditions, creating an isolated environment that reduces the risk of exposure while allowing patient monitoring and care throughout the mission.
The AVIO configuration introduces specific engineering solutions developed for aeronautical use. The patient restraint system has been redesigned with internal containment devices at the shoulders and lower limbs, integrated into the base of the chamber.
Dedicated structural aluminum anchors connect the isolation chamber to the support stretcher, helping to maintain required performance under load and emergency conditions. Dedicated support and restraint systems also ensure the proper securing of the blower and filtration units during flight maneuvers, landing operations, and emergency conditions. Critical components and materials have been selected to meet aviation requirements regarding flammability, maneuver loads, and emergency landing conditions.
The installation of the N36 AVIO system obtained certification through the issuance of EASA Supplemental Type Certificate No. 10090346, issued on July 8, 2026, for the installation of the IsoArk N36 biocontainment system on Leonardo AW139 helicopters equipped with approved Aerolite EMS stretcher systems.
The certification covers aeronautical installation approval, integration on the AW139, use in approved EMS configurations, structural verification of the installation, continued airworthiness documentation, and verification of compliance with aviation safety requirements.
The EASA certification obtained on the AW139 provides a solid baseline for extending the N36 AVIO concept to other aeronautical platforms. The design, integration, and compliance heritage already established can facilitate the development of new installations on additional rotary-wing and fixed-wing configurations, in compliance with the certification requirements applicable to each aircraft.
The N36 AVIO is intended to support a wide range of operational scenarios, including HEMS, MEDEVAC, and CASEVAC missions, humanitarian response, CBRN operations, pandemic emergencies, military medical support, and government emergency services.
The configuration is designed to preserve the aircraft's operational capability while ensuring a protected environment for patient transport. The system integrates a chamber configuration with flame-retardant materials, a restraint architecture dedicated to in-flight use, a structural stretcher anchoring system, adjustable supports for the filtration system, interoperability across air, land, and maritime transport, ease of use and handling, and a high level of biocontainment.
N36 AVIO therefore represents a dedicated solution for the protected air transport of infectious patients, combining biocontainment technology, certified aeronautical integration, and operational flexibility.
We and selected third parties use cookies or similar technologies for technical purposes and, with your consent,
also for other purposes as specified in the .
If you close this banner with a tick or click on "Decline", only technical cookies will be used. If you want to select the
cookies to be installed, click on 'Customise'. If you prefer, you can consent to the use of all cookies, including
cookies other than technical cookies, by clicking on "Accept all". You can change your choice at any time.